Search Within

Ezra Y Rosen

Formats
  1. Meeting Abstract (27)
  2. Journal Article (20)
  3. Editorial (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Department of Medicine (50)
  2. Early Drug Development Service (50)
  3. Hematology-Oncology Fellows (50)
  4. Solid Tumor Oncology Division (50)
  5. Weinberg Fellows (50)
  6. GSK Faculty (27)

More Groups

People
  1. Alexander Drilon (23)
  2. Alison Schram (12)
  3. Marc Ladanyi (11)
  4. David Hyman (10)
  5. Mark Donoghue (9)
  6. Michael Berger (9)

More People

Years
  1. 2025 (2)
  2. 2024 (11)
  3. 2023 (10)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (13)
  2. Annals of Oncology (9)
  3. Clinical Cancer Research (7)
  4. Cancer Research (4)
  5. JCO Precision Oncology (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (12)
  3. Oxford University Press (11)
  4. Nature Publishing Group (4)
  5. Elsevier Inc. (2)
  6. American Medical Association (1)

More Publishers

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CCNE1 amplification as marker of poor prognosis and novel therapeutic target in advanced breast cancer
    Meeting Abstract

    Marra, A.; Selenica, P.; Zhu, Y.; Safonov, A.; Razavi, P.; Roulston, A.; Koehler, M.; Curigliano, G.; Ross, D. S.; Weigelt, B.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancer
    Journal Article

    Mai, N.; Chen, J. F.; Rana, S.; Robson, M.; Chandarlapaty, S.; Rosen, E. Y.
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Development of a practical nomogram for personalized anemia management in patients treated with ataxia telangiectasia and Rad3-related inhibitor camonsertib
    Journal Article

    Rosen, E.; Yap, T. A.; Lee, E. K.; Højgaard, M.; Mettu, N. B.; Lheureux, S.; Carneiro, B. A.; Plummer, R.; Fretland, A. J.; Ulanet, D.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Detection of alternative lengthening of telomeres (ALT) across cancer types based on tumor-normal multigene panel sequencing
    Meeting Abstract

    Heredia, J. B.; Diplas, B. H.; El Nahhas, O. S. M.; Selenica, P.; Pareja, F.; Mandelker, D.; Weigelt, B.; Riaz, N.; Rosen, E.; Sfeir, A.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers
    Meeting Abstract

    Chen, M. F.; Rosen, E.; Falcon, C.; Repetto, M.; Yang, S. R.; Chang, J.; Kris, M. G.; Rekhtman, N.; Donoghue, M.; Drilon, A.
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • EZH2 inhibition: It's all about the context
    Editorial

    Rosen, E. Y.; Shukla, N. N.; Glade Bender, J. L.
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
    Journal Article

    Mandelker, D.; Marra, A.; Zheng-Lin, B.; Selenica, P.; Blanco-Heredia, J.; Zhu, Y.; Gazzo, A.; Wong, D.; Yelskaya, Z.; Rai, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1/2 study of CFT1946, a novel, bifunctional degradation activating compound (BIDAC) degrader, of mutant BRAF V600 as monotherapy and in combination with trametinib, in mutant BRAF V600 solid tumors
    Meeting Abstract

    McKean, M.; Spira, A. I.; Rosen, E.; Subbiah, V.; Moreno, V.; Gambardella, V.; Vieito, M.; Saavedra, O.; Cousin, S.; Cassier, P. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of solid tumors with BRAF fusions
    Meeting Abstract

    Chen, M. F.; Yang, S. R.; Tao, J.; Desilets, A.; Rosen, E.; Gong, Y.; Mullaney, K. A.; Kris, M. G.; Arcila, M. E.; Donoghue, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • MYC amplification segment-size mutual exclusivity analysis with other oncogenic events in a pan-cancer sequencing cohort
    Meeting Abstract

    Repetto, M.; Richards, A. L.; Chen, M. F.; Zhu, Y.; Selenica, P.; Gazzo, A.; Lee, P.; Price, A.; Yang, S. R.; Marra, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save